Budget impact analysis of comprehensive genomic profiling in patients with advanced non-small cell lung cancer
出版年份 2018 全文链接
标题
Budget impact analysis of comprehensive genomic profiling in patients with advanced non-small cell lung cancer
作者
关键词
-
出版物
JOURNAL OF MEDICAL ECONOMICS
Volume -, Issue -, Pages 1-11
出版商
Informa UK Limited
发表日期
2018-11-20
DOI
10.1080/13696998.2018.1549056
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Treatment Patterns and Clinical Outcomes Among Metastatic Non–Small-Cell Lung Cancer Patients Treated in the Community Practice Setting
- (2018) Eric Nadler et al. Clinical Lung Cancer
- Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non–Small Cell Lung Cancer in the Community Oncology Setting
- (2018) Carolyn J. Presley et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Broad-Based Molecular Testing for Lung Cancer
- (2018) Paul A. Bunn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Personalized, molecularly matched combination therapies for treatment-na.
- (2017) Jason K. Sicklick et al. JOURNAL OF CLINICAL ONCOLOGY
- Precision Diagnosis and Treatment for Advanced Non–Small-Cell Lung Cancer
- (2017) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs
- (2017) Derrick S. Haslem et al. Journal of Oncology Practice
- Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study
- (2016) Jennifer J. Wheler et al. CANCER RESEARCH
- Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular Testing
- (2016) A. B. Schrock et al. CLINICAL CANCER RESEARCH
- The cost of molecular-guided therapy in oncology: a prospective cost study alongside the MOSCATO trial
- (2016) Arnaud Pagès et al. GENETICS IN MEDICINE
- Nivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
- (2016) Scott Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis
- (2016) Linda M. Sabatini et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
- (2016) Fabrice Barlesi et al. LANCET
- Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience
- (2016) M. Schwaederle et al. MOLECULAR CANCER THERAPEUTICS
- Clinical Implications of Genomic Discoveries in Lung Cancer
- (2016) Charles Swanton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Value-Based Care in Lung Cancer
- (2016) K. D. Eaton et al. ONCOLOGIST
- Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials
- (2016) James H. Suh et al. ONCOLOGIST
- Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK -Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
- (2016) Siraj M. Ali et al. ONCOLOGIST
- Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States
- (2016) Lindsey Enewold et al. PLoS One
- The next steps in next-gen sequencing of cancer genomes
- (2015) D. Neil Hayes et al. JOURNAL OF CLINICAL INVESTIGATION
- Basket Trials and the Evolution of Clinical Trial Design in an Era of Genomic Medicine
- (2015) Amanda J. Redig et al. JOURNAL OF CLINICAL ONCOLOGY
- Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non–small-cell Lung Cancer
- (2015) Sarayut L Geater et al. Journal of Thoracic Oncology
- On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients
- (2015) M. Schwaederle et al. MOLECULAR CANCER THERAPEUTICS
- NCI-MATCH trial pushes cancer umbrella trial paradigm
- (2015) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations
- (2015) B. P. Levy et al. ONCOLOGIST
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical next-generation sequencing in patients with non-small cell lung cancer
- (2014) Ian S. Hagemann et al. CANCER
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- (2014) Mark G. Kris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Patient-Reported Outcomes and Quality of Life in PROFILE 1007: A Randomized Trial of Crizotinib Compared with Chemotherapy in Previously Treated Patients with ALK-Positive Advanced Non–Small-Cell Lung Cancer
- (2014) Fiona Blackhall et al. Journal of Thoracic Oncology
- First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
- (2014) Benjamin J. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel
- (2014) D. B. Johnson et al. ONCOLOGIST
- A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)
- (2014) Ansgar Lange et al. BMC Pulmonary Medicine
- The Impact of Genomic Changes on Treatment of Lung Cancer
- (2013) Stephanie Cardarella et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)
- (2013) G. Chen et al. ANNALS OF ONCOLOGY
- New Targetable Oncogenes in Non–Small-Cell Lung Cancer
- (2013) Geoffrey R. Oxnard et al. JOURNAL OF CLINICAL ONCOLOGY
- Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma WithEGFRMutations
- (2013) James Chih-Hsin Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Targets in Non-Small Cell Lung Cancer: ROS1 and RET Fusions
- (2013) J. F. Gainor et al. ONCOLOGIST
- Mammography Screening: A New Estimate of Number Needed to Screen to Prevent One Breast Cancer Death
- (2012) R. Edward Hendrick et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Genetic Changes in Squamous Cell Lung Cancer: A Review
- (2012) Rebecca S. Heist et al. Journal of Thoracic Oncology
- Cost Effectiveness of Personalized Therapy for First-Line Treatment of Stage IV and Recurrent Incurable Adenocarcinoma of the Lung
- (2012) Elizabeth A. Handorf et al. Journal of Oncology Practice
- Sex-Specific Prevalence of Adenomas, Advanced Adenomas, and Colorectal Cancer in Individuals Undergoing Screening Colonoscopy
- (2011) Monika Ferlitsch et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Projections of the Cost of Cancer Care in the United States: 2010-2020
- (2011) A. B. Mariotto et al. JNCI-Journal of the National Cancer Institute
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now